BD Names Bridget Bagnato Worldwide President of Peripheral Intervention
Article excerpt
Highlighted: the sentence this signal was extracted from
FRANKLIN LAKES, N.J., Nov. 4, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral Intervention business unit, effective November 16. Based at Peripheral Intervention's headquarters in Tempe, Arizona, Bagnato will be responsible for driving the business unit's global strategic, operational and commercial performance. She will report to Peter Menziuso, executive vice president and president of the Interventional segment. "Bridget brings deep experience across BD and a strong understanding of our customers, with a proven ability to grow businesses through innovation and operational excellence," said Menziuso. "I'm confident she will build on Peripheral Intervention's strong foundation, advancing differentiated technologies across peripheral vascular disease, oncology, and end-stage kidney disease to address significant unmet needs and deliver greater value for customers and patients." Bagnato currently serves as worldwide president of BD's Specimen Management business unit. During her more than 27 years at the company, she has held leadership roles across a range of BD businesses, including in Medication Delivery Solutions and Surgery, where she served as vice president and general manager of Surgical Complication...
Keep reading with a free account
The rest of this article, and every signal for BD, is in your free account.
